Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE2014/0754Aexternal-prioritypatent/BE1021251B1/en
Application filed by Iteos TherapeuticsfiledCriticalIteos Therapeutics
Publication of MA39993ApublicationCriticalpatent/MA39993A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to compound of formula (i) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of formula (i) as id01 inhibitors. The invention also relates to the use of the compounds of formula i for the treatment and/or prevention of cancer and endometriosis. The invention also relates to a process for manufacturing compounds of formula (i).
MA039993A2014-05-152015-05-14Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors
MA39993A
(en)